Lifitegrast
RxNorm 1801820· ATC S01XA25· lifitegrast
U.S. drug label (openFDA)
Xiidra — indications, dosage, warnings, adverse events →Kimya (PubChem)
- Moleküler formül
- C29H24Cl2N2O7S
- Moleküler ağırlık
- 615.5 g/mol
- IUPAC adı
- (2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
- InChIKey
- JFOZKMSJYSPYLN-QHCPKHFHSA-N